Marc D. Beer, Chief Executive Officer at Aegerion Pharmaceuticals, Inc. (AEGR), bought 6,754 shares at $14.75 ($100K) on 2011-09-01, disclosed to the SEC on 2011-09-06.
Scheduled purchase ($100k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.75 | 5,270 | $78K | 78.0% |
| 2 | $14.76 | 1,484 | $22K | 22.0% |
| Total | $14.75 avg | 6,754 | $100K | 100% |
| Filing → |
| BTMD | SELL | 2023-01-10 | $2.6M | — | Filing → |
| NERV | BUY | 2017-03-21 | $406K | — | Filing → |
| AEGR | BUY | 2014-07-31 | $337K | — | Filing → |